After a brutal start to the month for cannabis investors, the ETF MANAGERS TR/TIERRA XP LATIN AME MJ has rallied 8.6% this week on the heels of a Canopy Growth Corp CGC upgrade by Bank of America.
Bank of America upgraded Canopy to Buy on Wednesday, triggering a 30.9% two-day rally in Canopy shares and bullish sympathy trading in other popular cannabis stocks.
The Numbers
Short sellers have aggressively piled into cannabis stocks in 2019, with short interest up $389 million to $3.5 billion year to date. Short sellers are paying a steep price to bet against cannabis, with the average cost to borrow at 23.4% for cannabis stocks.
Aurora Cannabis Inc ACB is the most expensive cannabis stock to short with a 66.5% borrow fee.
Even after this week’s rally, Canopy shares are still down 25.5% year to date and remain the most profitable cannabis short of the year. As of Wednesday, Canopy short sellers were sitting on a year-to-date profit of $332.4 billion.
Reallocation Ahead?
Prior to this week’s rally, the month of November had been a home run for cannabis short sellers, who were up $499.7 million this month. Those gains took a $272 million hit on Wednesday, and short sellers are on track for another day of heavy losses on Thursday morning as well.
S3 Partners analyst Ihor Dusaniwsky said traders can expect Canopy short sellers to reallocate to more attractive cannabis short targets.
“Shorts will probably reallocate their exposure to other stocks in the sector as turnarounds occur, but not swap into another sector until a more widespread rally begins,” Dusaniwsky said.
The following are the five largest cannabis short positions as of Wednesday:
- Canopy Growth: $836.8 million in short interest.
- GW Pharmaceuticals PLC- ADR GWPH : $544.8 million in short interest.
- Aurora Cannabis: $435.9 million in short interest.
- Cronos Group Inc CRON: $373.7 million in short interest.
- Aphria Inc APHA: $169.5 million in short interest.
Benzinga’s Take
Cannabis stocks will likely continue to be volatile in the near term while the industry matures. Investors should be cautious about reading too much into this week’s bounce until underlying cannabis market fundamentals show real signs of improvement.
Do you agree with this take? Email feedback@benzinga.com with your thoughts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.